Bibliographic details
Lee KK, Cipriano LE, Owens DK, Go AS, Hlatky MA. Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate-and low-cardiovascular-risk individuals for statin therapy. Circulation 2010; 122(15): 1478-1487
MeSH
Adult; Aged; C-Reactive Protein /metabolism; Cost-Benefit Analysis; Decision Support Techniques; Female; Health Planning Guidelines; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors /economics /therapeutic use; Lipids /blood; Male; Middle Aged; Myocardial Infarction /epidemiology /prevention & Patient Selection; Quality-Adjusted Life Years; Risk; Sensitivity and Specificity; Stroke /epidemiology /prevention & control; control